Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Benzinga · 1d ago
Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.